نتائج البحث

Cost-utility analysis of atezolizumab with bevacizumab in untreated unresectable or advanced hepatocellular carcinoma in France.

• Authors : Gaugain, Loïg¹ (AUTHOR); Cawston, Hélène² (AUTHOR) ; Dubois de Gennes, Coline³ (AUTHOR)

Subjects: *COST effectiveness; *HEPATOCELLULAR carcinoma; *ATEZOLIZUMABFRANCE

• Source: PLoS ONE. 1/18/2023, Vol. 17 Issue 1, p1-12. 12p.

تفاصيل العنوان

Cost-Utility Analysis of STN1013001, a Latanoprost Cationic Emulsion, versus Other Latanoprost Formulations (Latanoprost) in Open-Angle Glaucoma or Ocular Hypertension and Ocular Surface Disease in France.

• Authors : Lazzaro, Carlo¹ (AUTHOR); van Steen, Cécile² (AUTHOR); Aptel, Florent³ (AUTHOR)

• Source: Journal of Ophthalmology. 4/29/2022, p1-13. 13p.

تفاصيل العنوان

Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial.

• Authors : Nguyen-Soenen, Jérôme^1,2 (AUTHOR) ; Rat, Cédric¹ (AUTHOR); Gaultier, Aurélie^1,3 (AUTHOR)

• Source: BMC Health Services Research. 2/17/2022, Vol. 22 Issue 1, p1-10. 10p. 2 Diagrams, 3 Charts.

تفاصيل العنوان

Cost–Utility Analysis of Nivolumab in Adjuvant Treatment of Melanoma in France.

• Authors : Bregman, Bruno¹ (AUTHOR) ; Teitsson, Siguroli² (AUTHOR); Orsini, Isabella² (AUTHOR)

• Source: Dermatology & Therapy. Dec2020, Vol. 10 Issue 6, p1331-1343. 13p.

تفاصيل العنوان

Cost-effectiveness of left atrial appendage occlusion during cardiac surgery in France: An economic evaluation based on the LAAOS III study.

• Authors : Benmalek M; Pharmacy Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.; Connock M

Subjects: Atrial Appendage*/Atrial Appendage*/Atrial Appendage*/surgery ; Cost-Benefit Analysis* ; Cardiac Surgical Procedures*/Cardiac Surgical Procedures*/Cardiac Surgical Procedures*/adverse effects

• Source: PloS one [PLoS One] 2024 May 09; Vol. 19 (5), pp. e0302517. Date of Electronic Publication: 2024 May 09 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Photocoagulation or sham laser in addition to conventional anti-VEGF therapy in macular edema associated with TelCaps due to diabetic macular edema or retinal vein occlusion (TalaDME): a study protocol for a multicentric, French, two-group, non-commercial, active-control, observer-masked, non-inferiority, randomized controlled clinical trial.

• Authors : Dupas B; Service d'ophtalmologie, Hôpital Lariboisière, AP-HP Nord, Université Paris Cité, Paris, France. .; FRCRnet/FCRIN Network, Paris, France. .

Subjects: Macular Edema*/Macular Edema*/Macular Edema*/etiology ; Macular Edema*/Macular Edema*/Macular Edema*/drug therapy ; Macular Edema*/Macular Edema*/Macular Edema*/surgery

• Source: Trials [Trials] 2024 Apr 22; Vol. 25 (1), pp. 273. Date of Electronic Publication: 2024 Apr 22.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: update to the study protocol for a randomized controlled trial.

• Authors : Couderc AL; Service de Médecine Interne Gériatrie et Thérapeutique, CHU Sainte Marguerite, Assistance Publique des Hôpitaux de Marseille (AP-HM), 270 Boulevard de Sainte Marguerite Dromel, 13274, Marseille, cedex 09, France.; Unit of Coordination in Onco-Geriatry (UCOG), PACA-west, France.

Subjects: Home Care Services*/Home Care Services*/Home Care Services*/economics ; Social Isolation*; Aging/Aging/Aging/*psychology

• Source: Trials [Trials] 2019 Jan 15; Vol. 20 (1), pp. 54. Date of Electronic Publication: 2019 Jan 15.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France.

• Authors : Maunoury F; Statesia, Le Mans, France.; Clément A

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*economics ; Cost-Benefit Analysis/Cost-Benefit Analysis/Cost-Benefit Analysis/*methods ; Hepatitis C, Chronic/Hepatitis C, Chronic/Hepatitis C, Chronic/*drug therapy

• Source: PloS one [PLoS One] 2018 Mar 15; Vol. 13 (3), pp. e0194329. Date of Electronic Publication: 2018 Mar 15 (Print Publication: 2018).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان